Syncope in Cataluña SYNCAT

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Medtronic Bakken Research Center
ClinicalTrials.gov Identifier:
NCT01721369
First received: June 19, 2012
Last updated: April 8, 2014
Last verified: April 2014
  Purpose

The SYNCAT study intention is to study the level of adherence of the centers in Cataluña tu the Syncope Guidelines ESC2009 for the diagnosis and treatment of syncope and the impact that following them can have in the prognosis of these patients.


Condition
Brief Loss of Consciousness

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Observational Study of the Application of the ESC2009 Syncope Guidelines in Cataluña

Resource links provided by NLM:


Further study details as provided by Medtronic Bakken Research Center:

Primary Outcome Measures:
  • Correct application of Guidelines [ Time Frame: 1 year follow up ] [ Designated as safety issue: No ]
    Percentage of patients in which the guidelines have been correctly applied for the evaluation of syncope


Enrollment: 581
Study Start Date: November 2011
Study Completion Date: March 2013
Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   15 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients with Transient Loss of Conscience: T-LOC

Criteria

Inclusion Criteria:

  • Each patient that comes from the Emergency room and/or in office doctors visit (Internal Medicine, Cardiology, Neurology...) with Transient Loss of Conscience (T-LOC)

Exclusion Criteria:

  • Patients younger than 15 years old
  • Pregnant women
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01721369

Sponsors and Collaborators
Medtronic Bakken Research Center
Investigators
Principal Investigator: Angel Moya, Dr. Hospital Vall d'Hebron
Principal Investigator: Jordi Tomàs, Dr. H. Arnau de Vilanova de Lleida
Principal Investigator: Joan Nicolàs, Dr. Parc Sanitari Sant Joan de Déu
Principal Investigator: Jordi Mercè, Dr. H. Joan XXIII
Principal Investigator: Francesc Planas, Dr. H. Municipal de Badalona
  More Information

No publications provided

Responsible Party: Medtronic Bakken Research Center
ClinicalTrials.gov Identifier: NCT01721369     History of Changes
Other Study ID Numbers: SYNCAT
Study First Received: June 19, 2012
Last Updated: April 8, 2014
Health Authority: Spain: Agencia Española de Medicamentos y Productos Sanitarios

Additional relevant MeSH terms:
Unconsciousness
Consciousness Disorders
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on July 31, 2014